104 related articles for article (PubMed ID: 12459369)
1. Assessment of quality of life and oral function of patients participating in a phase II study of radioprotection of oral and pharyngeal mucosa by the prostaglandin E(1) analog misoprostol (RTOG 96-07).
Johnson DJ; Scott CB; Marks JE; Seay TE; Atkins JN; Berk LB; Meoz RT; Wheeler JA
Int J Radiat Oncol Biol Phys; 2002 Dec; 54(5):1455-9. PubMed ID: 12459369
[TBL] [Abstract][Full Text] [Related]
2. Protection from radiation-induced oral mucositis by a mouth rinse containing the prostaglandin E1 analog, misoprostol: a placebo controlled double blind clinical trial.
Hanson WR; Marks JE; Reddy SP; Simon S; Mihalo WE; Tova Y
Adv Exp Med Biol; 1997; 400B():811-8. PubMed ID: 9547633
[No Abstract] [Full Text] [Related]
3. Oral monilia study on patients with head and neck cancer during radiotherapy.
Chen TY; Webster JH
Cancer; 1974 Aug; 34(2):246-9. PubMed ID: 4604859
[No Abstract] [Full Text] [Related]
4. Irradiation scheme using three daily fractions in the radiation therapy of pharyngeal and oral carcinomas.
Durkovský J; Jancina J; Siracká E; Krajci M
Neoplasma; 1984; 31(2):213-22. PubMed ID: 6717690
[TBL] [Abstract][Full Text] [Related]
5. Time factor in postoperative radiotherapy: a multivariate locoregional control analysis in 868 patients.
Suwinski R; Sowa A; Rutkowski T; Wydmanski J; Tarnawski R; Maciejewski B
Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):399-412. PubMed ID: 12738315
[TBL] [Abstract][Full Text] [Related]
6. Development of a head and neck companion module for the quality of life-radiation therapy instrument (QOL-RTI).
Trotti A; Johnson DJ; Gwede C; Casey L; Sauder B; Cantor A; Pearlman J
Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):257-61. PubMed ID: 9788402
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant intravenous methotrexate or definitive radiotherapy alone for advanced squamous cancers of the oral cavity, oropharynx, supraglottic larynx or hypopharynx.
Fazekas JT; Sommer C; Kramer S
Int J Radiat Oncol Biol Phys; 1980 May; 6(5):533-41. PubMed ID: 7410127
[No Abstract] [Full Text] [Related]
8. Planned preoperative irradiation and surgery for advanced cancer of the oral cavity, pharynx and larynx.
Roswit B; Spiro RH; Kolson H; Lin PY
Am J Roentgenol Radium Ther Nucl Med; 1972 Jan; 114(1):59-62. PubMed ID: 5009416
[No Abstract] [Full Text] [Related]
9. Dose-response for local control with hyperfractionated radiation therapy in advanced carcinomas of the upper aerodigestive tracts: preliminary report of radiation therapy oncology group protocol 83-13.
Cox JD; Pajak TF; Marcial VA; Hanks GE; Mohiuddin M; Fu KK; Byhardt RW; Rubin P
Int J Radiat Oncol Biol Phys; 1990 Mar; 18(3):515-21. PubMed ID: 2180866
[TBL] [Abstract][Full Text] [Related]
10. Accelerated versus conventional fractionated postoperative radiotherapy for advanced head and neck cancer: results of a multicenter Phase III study.
Sanguineti G; Richetti A; Bignardi M; Corvo' R; Gabriele P; Sormani MP; Antognoni P
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):762-71. PubMed ID: 15708255
[TBL] [Abstract][Full Text] [Related]
11. Randomized phase III trial of postoperative radiochemotherapy +/- amifostine in head and neck cancer. Is there evidence for radioprotection?
Vacha P; Fehlauer F; Mahlmann B; Marx M; Hinke A; Sommer K; Richter E; Feyerabend T
Strahlenther Onkol; 2003 Jun; 179(6):385-9. PubMed ID: 12789464
[TBL] [Abstract][Full Text] [Related]
12. Decreased acute toxicity by using midline mucosa-sparing blocks during radiation therapy for carcinoma of the oral cavity, oropharynx, and nasopharynx.
Perch SJ; Machtay M; Markiewicz DA; Kligerman MM
Radiology; 1995 Dec; 197(3):863-6. PubMed ID: 7480771
[TBL] [Abstract][Full Text] [Related]
13. [Accelerated hyperfractionated radiotherapy combined with simultaneous chemotherapy in locally advanced pharyngeal and oral carcinomas].
Stuschke M; Budach V; Dinges S; Jahnke K; Budach W; Heselmann I; Unger A; Stüben G; Sack H
Strahlenther Onkol; 1994 Dec; 170(12):689-99. PubMed ID: 7817270
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of radio-epithelitis with methacyl and meradine].
Maniuta AI
Med Radiol (Mosk); 1971 Aug; 16(8):32-6. PubMed ID: 5145955
[No Abstract] [Full Text] [Related]
15. Elective lymph node irradiation with intensity-modulated radiotherapy: is conventional dose fractionation necessary?
Bedi M; Firat S; Semenenko VA; Schultz C; Tripp P; Byhardt R; Wang D
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):e87-92. PubMed ID: 22516389
[TBL] [Abstract][Full Text] [Related]
16. Use of topical misoprostol to reduce radiation-induced mucositis: results of a randomized, double-blind, placebo-controlled trial.
Veness MJ; Foroudi F; Gebski V; Timms I; Sathiyaseelan Y; Cakir B; Tiver KW
Australas Radiol; 2006 Oct; 50(5):468-74. PubMed ID: 16981945
[TBL] [Abstract][Full Text] [Related]
17. The results of radiotherapy with high pressure oxygen in carcinoma of the pharynx, larynx and oral cavity.
Hurley RA; Richter W; Torrens L
Br J Radiol; 1972 Feb; 45(530):98-109. PubMed ID: 5058150
[No Abstract] [Full Text] [Related]
18. Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I-II trial.
Kuhnt T; Becker A; Pigorsch S; Pelz T; Bloching M; Passmann M; Lotterer E; Hänsgen G; Dunst J
Strahlenther Onkol; 2003 Oct; 179(10):673-81. PubMed ID: 14566475
[TBL] [Abstract][Full Text] [Related]
19. Low dose irradiation in advanced tumours of head and neck.
Pierquin B; Baillet F; Brown CH
Acta Radiol Ther Phys Biol; 1975 Dec; 14(6):497-504. PubMed ID: 1224991
[TBL] [Abstract][Full Text] [Related]
20. P105 as a prognostic indicator in patients irradiated for locally advanced head-and-neck cancer: a clinical/laboratory correlative analysis of RTOG-9003.
Hammond E; Berkey BA; Fu KK; Trotti A; Meredith RF; Jones CU; Byhardt R; Horwitz EM; Ang KK
Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):683-92. PubMed ID: 14529772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
